RNA R&D to Revenue
Atrium Therapeutics Inc · R&D to Revenue
RNA R&D to Revenue
Latest reported288.73%period ending
RNA FY R&D/Revenue (288.73% → 288.73%)
Latest values, visible window
More history is needed to export this chart.
RNA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 288.7313% |